BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11725182)

  • 1. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
    Keltner JL; Thirkill CE; Yip PT
    J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
    Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
    Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
    Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
    Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal findings in melanoma-associated retinopathy.
    Borkowski LM; Grover S; Fishman GA; Jampol LM
    Am J Ophthalmol; 2001 Aug; 132(2):273-5. PubMed ID: 11476700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
    Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
    Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
    Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D
    Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma-associated retinopathy: does autoimmunity prolong survival?
    Chan C; O'Day J
    Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
    Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
    Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral manifestation of melanoma-associated retinopathy.
    Janáky M; Pálffy A; Kolozsvári L; Benedek G
    Arch Ophthalmol; 2002 Jun; 120(6):866-7. PubMed ID: 12049605
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.
    Pföhler C; Haus A; Palmowski A; Ugurel S; Ruprecht KW; Thirkill CE; Tilgen W; Reinhold U
    Br J Dermatol; 2003 Jul; 149(1):74-8. PubMed ID: 12890197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.
    Jacobzone C; Cochard-Marianowski C; Kupfer I; Bettembourg S; Dordain Y; Misery L; Cochener B; Sassolas B
    Arch Dermatol; 2004 Oct; 140(10):1258-61. PubMed ID: 15492190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma.
    Jacobson DM; Adamus G
    Am J Ophthalmol; 2001 Jun; 131(6):806-8. PubMed ID: 11384586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Node way out.
    Vaphiades MS; Brown H; Whitcup SM
    Surv Ophthalmol; 2000; 45(1):77-83. PubMed ID: 10946083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waldenström's macroglobulinemia-associated retinopathy.
    Sen HN; Chan CC; Caruso RC; Fariss RN; Nussenblatt RB; Buggage RR
    Ophthalmology; 2004 Mar; 111(3):535-9. PubMed ID: 15019332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe course of cutaneous melanoma associated paraneoplastic retinopathy.
    Kellner U; Bornfeld N; Foerster MH
    Br J Ophthalmol; 1995 Aug; 79(8):746-52. PubMed ID: 7547786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in visual fields in a patient with melanoma-associated retinopathy treated with intravenous immunoglobulin.
    Subhadra C; Dudek AZ; Rath PP; Lee MS
    J Neuroophthalmol; 2008 Mar; 28(1):23-6. PubMed ID: 18347454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal disease in neuro-ophthalmology: paraneoplastic retinopathy and the big blind spot syndrome.
    Volpe NJ; Rizzo JF
    Semin Ophthalmol; 1995 Sep; 10(3):234-41. PubMed ID: 10159748
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous melanoma-associated retinopathy.
    Kim RY; Retsas S; Fitzke FW; Arden GB; Bird AC
    Ophthalmology; 1994 Nov; 101(11):1837-43. PubMed ID: 7800366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.